Semilicoisoflavone B

CAS No. 129280-33-7

Semilicoisoflavone B( —— )

Catalog No. M31447 CAS No. 129280-33-7

Semilicoisoflavone B can inhibit sorbitol formation of rat lens incubated with a high concentration of glucose, indicates that it may be effective for preventing osmotic stress in hyperglycemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 954 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Semilicoisoflavone B
  • Note
    Research use only, not for human use.
  • Brief Description
    Semilicoisoflavone B can inhibit sorbitol formation of rat lens incubated with a high concentration of glucose, indicates that it may be effective for preventing osmotic stress in hyperglycemia.
  • Description
    Semilicoisoflavone B can inhibit sorbitol formation of rat lens incubated with a high concentration of glucose, indicates that it may be effective for preventing osmotic stress in hyperglycemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    129280-33-7
  • Formula Weight
    352.3
  • Molecular Formula
    C20H16O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (141.91 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TAT TFA (191936-91-1...

    TAT TFA (YGRKKRRQRRR) is derived from human immunodeficiency virus (hiv-1) transcription reverse activator TAT, is a cell penetrating peptide.

  • Bisphenol A

    Bisphenol A is a starting material for the synthesis of plastics primarily certain polycarbonates and epoxy resins as well as some polysulfones and certain niche materials. It exhibits estrogen-mimicking hormone-like properties.

  • Omalizumab

    Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).